American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 262.e1-262.e7, August 2005

Splendore-Hoeppli Phenomenon in the Conjunctiva: Immunohistochemical Analysis

Doheny Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California.

Accepted 2 March 2005. published online 16 June 2005.

Purpose

To present two cases of conjunctival lesions exhibiting the Splendore-Hoeppli phenomenon, each with different immunohistochemical findings.

Design

Interventional case reports.

Methods

Two young males with conjunctival lesions underwent biopsy. Demographic data and timing of biopsy were extracted from the charts. The biopsy specimens were formalin fixed and paraffin embedded for light microscopy. Immunohistochemical staining using the peroxidase method was carried out on each for IgG, IgM, IgA, the C3 component of complement, and eosinophilic major basic protein. main outcome measures: Presence of positive or negative staining for the various antigens.

Results

Both biopsy specimens exhibited the Splendore-Hoeppli phenomenon, a morphologically unique process consisting of an amorphous, eosinophilic material surrounded by epithelioid histiocytes, multinucleated giant cells, lymphocytes, and eosinophils. Two staining patterns were seen. One revealed predominately immunoglobulin deposition, whereas the other revealed primarily eosinophilic major basic protein. This is the first instance we are aware of in which eosinophilic major basic protein was the predominate finding in an ocular specimen.

Conclusion

The composition of Splendore-Hoeppli phenomenon material varies and may be related to various factors, including timing of biopsy and prior treatment.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by EY03040, National Eye Institute, Bethesda, Maryland and an unrestricted departmental grant from Research to Prevent Blindness, Inc, New York, New York.Dr Read is currently affiliated with the Departments of Ophthalmology and Pathology, University of Alabama School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

PII: S0002-9394(05)00308-9

doi:10.1016/j.ajo.2005.03.023

American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 262.e1-262.e7, August 2005